FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Pallansch

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Disease Outbreaks

Procedures

Genes & Molecular Sequences

Genome, Viral

Co-author Network

Publications

TOP 3
Cara Carthel Burns; Qi Chen; Paul Chenoweth; Alex Gasasira; Nicksy Gumede; Elizabeth Henderson; Jane Iber; Jaume Jorba; David R Kilpatrick; Asif Naeem; Yorihiro Nishimura; Steve Oberste; Mark A Pallansch; Muhammed Ali Pate; Jing Shaw; Hiroyuki Shimizu; Oyewale TOMORI; Rifqiyah Nur Umami; Annelet Vincent; Kathleen A Wannemuehler; Steven G Wassilak; A J Williams; Emmanuel Ade Abanida; Adekunle Adeniji; Festus Adu; Marycelin Baba; David Bukbuk; Olen M Kew
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.
Radboud J Duintjer Tebbens; Neal A Halsey; Tapani Hovi; Jong-Hoon Kim; Philip D Minor; John F Modlin; Mark A Pallansch; Peter A Patriarca; Roland W Sutter; Konstantin M Chumakov; Stephen L Cochi; Steven G F Wassilak; Peter F Wright; Kimberly M Thompson
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.
Radboud J Duintjer Tebbens; Dominika A Kalkowska; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Kimberly M Thompson
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Pallansch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cara Carthel Burns; Qi Chen; Paul Chenoweth; Alex Gasasira; Nicksy Gumede; Elizabeth Henderson; Jane Iber; Jaume Jorba; David R Kilpatrick; Asif Naeem; Yorihiro Nishimura; Steve Oberste; Mark A Pallansch; Muhammed Ali Pate; Jing Shaw; Hiroyuki Shimizu; Oyewale TOMORI; Rifqiyah Nur Umami; Annelet Vincent; Kathleen A Wannemuehler; Steven G Wassilak; A J Williams; Emmanuel Ade Abanida; Adekunle Adeniji; Festus Adu; Marycelin Baba; David Bukbuk; Olen M Kew
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.
Journal of virology 2013;87(9):4907-22.
2013: Radboud J Duintjer Tebbens; Neal A Halsey; Tapani Hovi; Jong-Hoon Kim; Philip D Minor; John F Modlin; Mark A Pallansch; Peter A Patriarca; Roland W Sutter; Konstantin M Chumakov; Stephen L Cochi; Steven G F Wassilak; Peter F Wright; Kimberly M Thompson
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):606-46.
2013: Radboud J Duintjer Tebbens; Dominika A Kalkowska; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Kimberly M Thompson
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):703-49.
2013: Radboud J Duintjer Tebbens; Olen M Kew; Jong-Hoon Kim; M Steven Oberste; Mark A Pallansch; Cara C Burns; Stephen L Cochi; Ousmane M Diop; Steven G F Wassilak; Kimberly M Thompson
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):680-702.
2013: Kimberly M Thompson; Steven G F Wassilak; Radboud J Duintjer Tebbens; Jong-Hoon Kim; Mark A Pallansch; Stephen L Cochi
Preeradication vaccine policy options for poliovirus infection and disease control.
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):516-43.
2013: Kimberly M Thompson; Steven G F Wassilak; Mark A Pallansch; Radboud J Duintjer Tebbens; Stephen L Cochi
Modeling population immunity to support efforts to end the transmission of live polioviruses.
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):647-63.
2013: Radboud J Duintjer Tebbens; Neal A Halsey; Tapani Hovi; Jong-Hoon Kim; Philip D Minor; John F Modlin; Mark A Pallansch; Peter A Patriarca; Roland W Sutter; Konstantin M Chumakov; Stephen L Cochi; Steven G F Wassilak; Peter F Wright; Kimberly M Thompson
Expert review on poliovirus immunity and transmission.
Risk analysis : an official publication of the Society for Risk Analysis 2013;33(4):544-605.
2013: Mark A Pallansch; M Steven Oberste
Enterovirus 71 encephalitis: a new vaccine on the horizon?
Lancet 2013;381(9871):976-7.
2013: Steve Oberste; Gunwha Oh; Mark A Pallansch; Kaija Maher; W Allan Nix; Sajeda Begum; Anwarul H Chowdhury; Gregory A Engel; Mohammed M Feeroz; Kamrul M Hasan; Lisa Jones-Engel
Characterizing the picornavirus landscape among synanthropic nonhuman primates in Bangladesh, 2007 to 2008.
Journal of virology 2013;87(1):558-71.
2013: Steve Oberste; Gunwha Oh; Mark A Pallansch; Kaija Maher; W Allan Nix; Sajeda Begum; Gregory A Engel; Mohammed M Feeroz; Kamrul M Hasan; Lisa Jones-Engel
Naturally acquired picornavirus infections in primates at the Dhaka zoo.
Journal of virology 2013;87(1):572-80.
2012: Hong-Mei Liu; Deborah Moore; Barbara Anderson; Marc S Collett; Mark A Pallansch; Daniel C Pevear; Jason A Roberts; M Steven Oberste
Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.
Antimicrobial agents and chemotherapy 2012;56(11):5568-74.
2012: Concepción F Estívariz; Sherine Guirguis; Hamid Jafari; Vibhor Jain; T Jacob John; Mark A Pallansch; Ajit P Singh; Roland W Sutter; Harish Verma; Ashutosh Agarwal; Jitendra Awale; Sunil Bahl; Anthony Burton; Arani Chatterjee; R Bruce Aylward
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
The Lancet infectious diseases 2012;12(2):128-35.
2012: Kimberly M Thompson; Gregory S Wallace; Radboud J Duintjer Tebbens; James P Alexander; Gregory L Armstrong; Albert E Barskey; Stephen L Cochi; Kathleen M Gallagher; Mark A Pallansch; Philip J Smith; Steven G F Wassilak
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.
Public health reports (Washington, D.C. : 1974) 2012;127(1):23-37.
2011: T Jacob John; Pradeep Malankar; Mark A Pallansch; Kanithi Ravishankar; Ajit Pal Singh; Meghana Sreevatsava; A Amaresh; Anthony Burton; Arani Chatterjee; Jagadish Deshpande; Hemant Jain; Harish Verma; Roland W Sutter
Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials.
Vaccine 2011;29(34):5793-801.
2011: Sucheta J Doshi; Karen J Hymbaugh; Mark A Pallansch; Hardeep S Sandhu; Linda V Venczel; Jay D Wenger; Sunil Bahl; Jagadish M Deshpande; Steve L Cochi
Poliomyelitis-related case-fatality ratio in India, 2002-2006.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(1):13-9.
2011: Steven G Wassilak; Muhammad Ali Pate; Kathleen A Wannemuehler; Julie Jenks; Cara Burns; Paul Chenoweth; Emmanuel Ade Abanida; Festus Adu; Marycelin Baba; Alex Gasasira; Jane Iber; Pascal Mkanda; A J Williams; Jing Shaw; Mark A Pallansch; Olen M Kew
Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.
The Journal of infectious diseases 2011;203(7):898-909.
2011: Susan L Baldwin; Christopher B Fox; Mark A Pallansch; Rhea N Coler; Steven G Reed; Martin Friede
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions.
Vaccine 2011;29(4):644-9.
2010: Radboud J Duintjer Tebbens; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Jennifer Linkins; Roland W Sutter; R Bruce Aylward; Kimberly M Thompson
Economic analysis of the global polio eradication initiative.
Vaccine 2010;29(2):334-43.
2010: Nino Khetsuriani; T Kutateladze; E Zangaladze; T Shutkova; Silvia Peñaranda; W Allan Nix; Mark A Pallansch; Steve Oberste
High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002-2005.
Journal of medical microbiology 2010;59(Pt 11):1340-7.
2010: W Allan Nix; Kaija Maher; Mark A Pallansch; Steve Oberste
Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;48(3):202-7.
2010: Ali Jafer Mohammed; Salah AlAwaidy; Shyam Bawikar; Padmamohan J Kurup; Emadaldin Elamir; Mahmoud M A Shaban; Sharif M Sharif; Harrie G A M van der Avoort; Mark A Pallansch; Pradeep Malankar; Anthony Burton; Meghana Sreevatsava; Roland W Sutter
Fractional doses of inactivated poliovirus vaccine in Oman.
The New England journal of medicine 2010;362(25):2351-9.
2010: Radboud J Duintjer Tebbens; Mark A Pallansch; James P Alexander; Kimberly M Thompson
Optimal vaccine stockpile design for an eradicated disease: application to polio.
Vaccine 2010;28(26):4312-27.
2010: Gerald Sedmak; W Allan Nix; Jeffrey M Jentzen; Thomas E Haupt; Jeffrey P Davis; Sanjib Bhattacharyya; Mark A Pallansch; M Steven Oberste
Infant deaths associated with human parechovirus infection in Wisconsin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(3):357-61.
2009: M Steven Oberste; Deborah Moore; Barbara Anderson; Mark A Pallansch; Daniel C Pevear; Marc S Collett
In vitro antiviral activity of V-073 against polioviruses.
Antimicrobial agents and chemotherapy 2009;53(10):4501-3.
2009: Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van Der Avoort
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.
Journal of virology 2009;83(17):8693-704.
2009: Betty A Brown; Kaija Maher; Mary R Flemister; Pejman Naraghi-Arani; Moyez Uddin; Steve Oberste; Mark A Pallansch
Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102.
The Journal of general virology 2009;90(Pt 7):1713-23.
2009: James P Alexander; Kristen Ehresmann; Jane Seward; Gary Wax; Kathleen Harriman; Susan Fuller; Elizabeth A Cebelinski; Qi Chen; Jaume Jorba; Olen M Kew; Mark A Pallansch; Steve Oberste; Mark Schleiss; Jeffrey P Davis; Bryna Warshawsky; Susan Squires; HF Hull
Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota.
The Journal of infectious diseases 2009;199(3):391-7.
2009: Nino Khetsuriani; Rita F Helfand; Mark A Pallansch; Olen M Kew; Ashley Fowlkes; Steve Oberste; Peter Tukei; Joseph Muli; Ernest Makokha; Howard E Gary
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.
BMC infectious diseases 2009;9():136.
2008: Ashley L Fowlkes; Somayeh Honarmand; Carol Glaser; Shigeo Yagi; David Schnurr; Steve Oberste; Larry Anderson; Mark A Pallansch; Nino Khetsuriani
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005.
The Journal of infectious diseases 2008;198(11):1685-91.
2008: Nasr el-Sayed; Yehia el-Gamal; Ahmed-Amr Abbassy; Iman Seoud; Maha Salama; Amr Kandeel; Elham Hossny; Ahmed Shawky; Heba Abou Hussein; Mark A Pallansch; Harrie G A M van der Avoort; Anthony H Burton; Meghana Sreevatsava; Pradeep Malankar; Mohamed H Wahdan; Roland W Sutter
Monovalent type 1 oral poliovirus vaccine in newborns.
The New England journal of medicine 2008;359(16):1655-65.
2008: Sebastian Zurbriggen; Kurt Tobler; Carlos Abril; Sabine Diedrich; Mathias Ackermann; Mark A Pallansch; Alfred Metzler
Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine.
Applied and environmental microbiology 2008;74(18):5608-14.
2008: Elizabeth M Begier; Steve Oberste; Marie L Landry; Timothy Brennan; Diana Mlynarski; Patricia Mshar; Kasia Frenette; Terry Rabatsky-Ehr; Katherine Purviance; Ava Nepaul; W Allan Nix; Mark A Pallansch; David Ferguson; ML Cartter; James L Hadler
An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):616-23.
2008: Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi; Kimberly M Thompson
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk management.
Risk analysis : an official publication of the Society for Risk Analysis 2008;28(4):855-76.
2008: Suxiang Tong; Shur-Wern Wang Chern; Yan Li; Mark A Pallansch; Larry J Anderson
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses.
Journal of clinical microbiology 2008;46(8):2652-8.
2008: W Allan Nix; Kaija Maher; E Susanne Johansson; Bo Niklasson; A Michael Lindberg; Mark A Pallansch; Steve Oberste
Detection of all known parechoviruses by real-time PCR.
Journal of clinical microbiology 2008;46(8):2519-24.
2008: Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
The risks, costs, and benefits of possible future global policies for managing polioviruses.
American journal of public health 2008;98(7):1322-30.
2008: Concepción F Estívariz; Margaret A Watkins; Darmawali Handoko; Rusipah Rusipah; Jagadish Deshpande; Bardan J Rana; Eveline Irawan; Dyah Widhiastuti; Mark A Pallansch; Arun Thapa; Sholah Imari
A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.
The Journal of infectious diseases 2008;197(3):347-54.
2008: Ionela Gouandjika-Vasilache; Cara C Burns; Nicksy Gumede; Sophie Guillot; Didier Menard; Annick Dosseh; Chantal Akoua-Koffi; Mark A Pallansch; Olen M Kew; Francis Delpeyroux
Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay.
Archives of virology 2008;153(3):409-16.
2007: Steve Oberste; Kaija Maher; Mark A Pallansch
Complete genome sequences for nine simian enteroviruses.
The Journal of general virology 2007;88(Pt 12):3360-72.
2007: Carlos M Pérez-Vélez; Marsha S Anderson; Christine C Robinson; Elizabeth J McFarland; W Allan Nix; Mark A Pallansch; Steve Oberste; Mary P Glodé
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(8):950-7.
2007: Jeannette Guarner; Julu Bhatnagar; Wun-Ju Shieh; Kurt B Nolte; Dennis Klein; Michelle S Gookin; Silvia Peñaranda; Steve Oberste; Tara Jones; Chalanda Smith; Mark A Pallansch; Sherif R Zaki
Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis.
Human pathology 2007;38(9):1412-9.
2007: Steve Oberste; Kaija Maher; W Allan Nix; Suzanne M Michele; Moyez Uddin; David Schnurr; Suleiman al-Busaidy; Chantal Akoua-Koffi; Mark A Pallansch
Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B.
Virus research 2007;128(1-2):34-42.
2007: Festus Adu; Jane Iber; David Bukbuk; Nicksy Gumede; Su-Ju Yang; Jaume Jorba; Ray Campagnoli; Waidi Folorunso Sule; Chen-Fu Yang; Cara Burns; Mark A Pallansch; Tekena Harry; Olen M Kew
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.
Virus research 2007;127(1):17-25.
2007: Nasr El-Sayed; Samir Al-Jorf; Karen A Hennessey; Maha Salama; Margaret A Watkins; Jalaa A Abdelwahab; Mark A Pallansch; Howard E Gary; Mohamed Helmy Wahdan; Roland W Sutter
Survey of poliovirus antibodies during the final stage of polio eradication in Egypt.
Vaccine 2007;25(27):5062-70.
2007: Steve Oberste; Kaija Maher; M A Patterson; Mark A Pallansch
The complete genome sequence for an American isolate of enterovirus 77.
Archives of virology 2007;152(8):1587-91.
2007: Gustavo H Dayan; Margaret Thorley; Yasuhiro Yamamura; Nayra Rodríguez; Steve McLaughlin; Lourdes M Torres; Antonio Seda; Marcia Carbia; Lorraine N Alexander; Victor Caceres; Mark A Pallansch
Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico.
The Journal of infectious diseases 2007;195(1):12-20.
2006: Mark A Pallansch; Hardeep S Sandhu
The eradication of polio--progress and challenges.
The New England journal of medicine 2006;355(24):2508-11.
2006: Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James P Alexander; Linda Venczel; Denise Johnson; Victor M Cáceres; Nalinee Sangrujee; Hamid Jafari; Stephen L Cochi
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling.
Risk analysis : an official publication of the Society for Risk Analysis 2006;26(6):1571-80.
2006: Esther de Gourville; Radboud J Duintjer Tebbens; Nalinee Sangrujee; Mark A Pallansch; Kimberly M Thompson
Global surveillance and the value of information: the case of the global polio laboratory network.
Risk analysis : an official publication of the Society for Risk Analysis 2006;26(6):1557-69.
2006: Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch
Evaluation of response scenarios to potential polio outbreaks using mathematical models.
Risk analysis : an official publication of the Society for Risk Analysis 2006;26(6):1541-56.
2006: Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Victor M Cáceres; Hamid Jafari; Stephen L Cochi; Roland W Sutter; R Bruce Aylward; Kimberly M Thompson
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
Risk analysis : an official publication of the Society for Risk Analysis 2006;26(6):1471-505.
2006: Walter R Dowdle; Harrie van Der Avoort; Esther de Gourville; Francis Delpeyroux; Jagadish Desphande; Tapani Hovi; Javier Martin; Mark A Pallansch; Olen M Kew; Chris Wolff
Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.
Risk analysis : an official publication of the Society for Risk Analysis 2006;26(6):1449-69.
2006: Nino Khetsuriani; Ashley C Lamonte; Steve Oberste; Mark A Pallansch
Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003.
The Pediatric infectious disease journal 2006;25(10):889-93.
2006: Nino Khetsuriani; Ashley Lamonte-Fowlkes; Steven Oberst; Mark A Pallansch
Enterovirus surveillance--United States, 1970-2005.
Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) 2006;55(8):1-20.
2006: W Allan Nix; Steve Oberste; Mark A Pallansch
Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens.
Journal of clinical microbiology 2006;44(8):2698-704.
2006: Steve Oberste; Kaija Maher; Alford J Williams; Naomi Dybdahl-Sissoko; Betty A Brown; Michelle S Gookin; Silvia Peñaranda; Nada Mishrik; Moyez Uddin; Mark A Pallansch
Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses.
The Journal of general virology 2006;87(Pt 1):119-28.
2005: Karen A Hennessey; Hugues Lago; Fabien Diomande; Chantal Akoua-Koffi; Victor M Caceres; Mark A Pallansch; Olen M Kew; Monica Nolan; Patrick L F Zuber
Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.
The Journal of infectious diseases 2005;192(12):2124-8.
2005: Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark A Pallansch; Tatsuo Miyamura; Olen M Kew; Jyh-Yuan Yang
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.
Journal of virology 2005;79(20):12623-34.
2005: Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Victor M Cáceres; Roland W Sutter; Kimberly M Thompson
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future.
American journal of epidemiology 2005;162(4):358-72.
2005: Q Sue Huang; Gail E Greening; Michael G Baker; Keith Grimwood; Joanne Hewitt; Debbie Hulston; Lisa van Duin; Amanda Fitzsimons; Nicholas (Nick) Garrett; David Graham; Diana Lennon; Hiroyuki Shimizu; Tatsuo Miyamura; Mark A Pallansch
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
Lancet 2005;366(9483):394-6.
2005: Tapani Hovi; Soile Blomqvist; Eman Nasr; Cara C Burns; Tarja Sarjakoski; Nahed Ahmed; Carita Savolainen; Merja Roivainen; Mirja Stenvik; Pia Laine; Ibrahim Barakat; Mohamed Helmy Wahdan; Faten A Kamel; Humayun Asghar; Mark A Pallansch; Olen M Kew; Howard E Gary; Esther M deGourville; Laila El Bassioni
Environmental surveillance of wild poliovirus circulation in Egypt--balancing between detection sensitivity and workload.
Journal of virological methods 2005;126(1-2):127-34.
2005: Steve Oberste; Kaija Maher; Suzanne M Michele; Gaël Belliot; Moyez Uddin; Mark A Pallansch
Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A.
The Journal of general virology 2005;86(Pt 2):445-51.
2005: Olen M Kew; Roland W Sutter; Esther de Gourville; Walter R Dowdle; Mark A Pallansch
Vaccine-derived polioviruses and the endgame strategy for global polio eradication.
Annual review of microbiology 2005;59():587-635.
2004: D Rebecca Prevots; F Brian Pascual; Mary Lu Angellili; Robert Brayden; Matilde Irigoyen; Philip S LaRussa; Mark Sawyer; Andrew L Baughman; Mark A Pallansch
Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
The Pediatric infectious disease journal 2004;23(12):1130-6.
2004: Hiroyuki Shimizu; Bruce R Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark A Pallansch; Olen M Kew; Tatsuo Miyamura
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.
Journal of virology 2004;78(24):13512-21.
2004: Steve Oberste; Suzanne M Michele; Kaija Maher; David Schnurr; Daniel Cisterna; Nina Junttila; Moyez Uddin; Jean-Jacques Chomel; Chi-Shan Lau; Walid Ridha; Suleiman al-Busaidy; Helene Norder; Lars O Magnius; Mark A Pallansch
Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75.
The Journal of general virology 2004;85(Pt 11):3205-12.
2004: Lorraine Niño Alexander; Jane F Seward; Tammy A Santibanez; Mark A Pallansch; Olen M Kew; D Rebecca Prevots; Peter Strebel; Joanne Cono; Melinda Wharton; Walter A Orenstein; Roland W Sutter
Vaccine policy changes and epidemiology of poliomyelitis in the United States.
JAMA : the journal of the American Medical Association 2004;292(14):1696-701.
2004: Suxiang Tong; Jaisri R Lingappa; Qi Chen; Bo Shu; Ashley C Lamonte; Byron T Cook; Charryse Birge; Shur-wern Wang Chern; Xin Liu; Renee L Galloway; Le Quynh Mai; Wai Fu Ng; Jyh-Yuan Yang; Jagdish Butany; James A Comer; Stephan S Monroe; Suzanne R Beard; Thomas G Ksiazek; Dean Erdman; Paul A Rota; Mark A Pallansch; Larry J Anderson
Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation.
The Journal of infectious diseases 2004;190(6):1127-31.
2004: David R Kilpatrick; Karen Ching; Jane Iber; Ray Campagnoli; Christopher J Freeman; Nada Mishrik; Hong-Mei Liu; Mark A Pallansch; Olen M Kew
Multiplex PCR method for identifying recombinant vaccine-related polioviruses.
Journal of clinical microbiology 2004;42(9):4313-5.
2004: Steve Oberste; Kaija Maher; David Schnurr; Mary R Flemister; Judith C Lovchik; Heather Peters; Wendy Sessions; Carol Kirk; Nando Chatterjee; Susan Fuller; J Michael Hanauer; Mark A Pallansch
Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses.
The Journal of general virology 2004;85(Pt 9):2577-84.
2004: Steve Oberste; Silvia Peñaranda; Kaija Maher; Mark A Pallansch
Complete genome sequences of all members of the species Human enterovirus A.
The Journal of general virology 2004;85(Pt 6):1597-607.
2004: W Allan Nix; M M Berger; Steve Oberste; B R Brooks; D M McKenna-Yasek; R H Brown; R P Roos; Mark A Pallansch
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method.
Neurology 2004;62(8):1372-7.
2004: Steve Oberste; Silvia Peñaranda; Mark A Pallansch
RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses.
Journal of virology 2004;78(6):2948-55.
2004: Olen M Kew; Peter F Wright; Vadim I Agol; Francis Delpeyroux; Hiroyuki Shimizu; Neal Nathanson; Mark A Pallansch
Circulating vaccine-derived polioviruses: current state of knowledge.
Bulletin of the World Health Organization 2004;82(1):16-23.
2004: Neal A Halsey; Jorge Pinto; Francisco Espinosa Rosales; María A Faure-Fontenla; Edson da Silva; Aamir J Khan; A David B Webster; Philip Minor; Glynis Dunn; Edwin J Asturias; Hamidah Hussain; Mark A Pallansch; Olen M Kew; Jerry A Winkelstein; Roland Sutter
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.
Bulletin of the World Health Organization 2004;82(1):3-8.
2004: Steve Oberste; Kaija Maher; Mark A Pallansch
Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes.
Journal of virology 2004;78(2):855-67.
2004: James A Mullins; Nino Khetsuriani; W Allan Nix; Steve Oberste; Ashley C Lamonte; David R Kilpatrick; James Dunn; Janine Langer; Peter McMinn; Q Sue Huang; Keith Grimwood; Cinnia Huang; Mark A Pallansch
Emergence of echovirus type 13 as a prominent enterovirus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(1):70-7.
2003: Nino Khetsuriani; D Rebecca Prevots; Linda Quick; Melissa E Elder; Mark A Pallansch; Olen M Kew; Roland W Sutter
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
The Journal of infectious diseases 2003;188(12):1845-52.
2003: Steve Oberste; Mark A Pallansch
Establishing evidence for enterovirus infection in chronic disease.
Annals of the New York Academy of Sciences 2003;1005():23-31.
2003: Laila El Bassioni; Ibrahim Barakat; Eman Nasr; Esther de Gourville; Tapani Hovi; Soile Blomqvist; Cara Burns; Mirja Stenvik; Howard E Gary; Olen M Kew; Mark A Pallansch; Mohamed Helmy Wahdan
Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt.
American journal of epidemiology 2003;158(8):807-15.
2003: Pedro Más Lago; Howard E Gary; Luis Sarmientos Pérez; Victor M Cáceres; Julio Barrios Olivera; Rosa Palomera Puentes; Marité Bello Corredor; Patricia Jímenez; Mark A Pallansch; Roberto González Cruz
Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba.
International journal of epidemiology 2003;32(5):772-7.
2003: Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; Steve Oberste; Olen M Kew; Mark A Pallansch
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.
Journal of virology 2003;77(20):10994-1005.
2003: Steve Oberste; Kaija Maher; Mark A Pallansch
Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae.
Virology 2003;314(1):283-93.
2003: Q Sue Huang; Julia M Carr; W Allan Nix; Steve Oberste; David R Kilpatrick; Mark A Pallansch; Margaret C Croxson; Jennifer A Lindeman; Michael G Baker; Keith Grimwood
An echovirus type 33 winter outbreak in New Zealand.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(5):650-7.
2003: Walter R Dowdle; Esther de Gourville; Olen M Kew; Mark A Pallansch; D Wood
Polio eradication: the OPV paradox.
Reviews in medical virology 2003;13(5):277-91.
2003: Betty Brown; Steve Oberste; Kaija Maher; Mark A Pallansch
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region.
Journal of virology 2003;77(16):8973-84.
2003: Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van Der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark A Pallansch; Olen M Kew
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.
Journal of virology 2003;77(15):8366-77.
2003: Keith Grimwood; Q Sue Huang; Lynette G Sadleir; W Allan Nix; David R Kilpatrick; Steve Oberste; Mark A Pallansch
Acute flaccid paralysis from echovirus type 33 infection.
Journal of clinical microbiology 2003;41(5):2230-2.
2003: Steve Oberste; W Allan Nix; Kaija Maher; Mark A Pallansch
Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;26(3):375-7.
2003: Steve Oberste; W Allan Nix; David R Kilpatrick; Mary R Flemister; Mark A Pallansch
Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East.
Virus research 2003;91(2):241-8.
2003: Patricia M Graves; Harley A Rotbart; William A Nix; Mark A Pallansch; Henry A Erlich; Jill M Norris; Michelle Hoffman; George S Eisenbarth; Marian Rewers
Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY).
Diabetes research and clinical practice 2003;59(1):51-61.
2002: Olen M Kew; Victoria Morris-Glasgow; Mauricio Landaverde; Cara Burns; Jing Shaw; Zacarías Garib; Jean André; Elizabeth Blackman; Christopher J Freeman; Jaume Jorba; Roland W Sutter; Gina Tambini; Linda Venczel; Cristina Pedreira; Fernando Laender; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Harrie van Der Avoort; Steve Oberste; David Kilpatrick; Stephen L Cochi; Mark A Pallansch; Ciro A de Quadros
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
Science (New York, N.Y.) 2002;296(5566):356-9.
2002: Steve Oberste; Kaija Maher; Mark A Pallansch
Molecular phylogeny and proposed classification of the simian picornaviruses.
Journal of virology 2002;76(3):1244-51.
2001: Pedro Más Lago; Victor M Cáceres; M A Galindo; Howard E Gary; M Valcarcel; Julio Barrios; Luis Sarmiento; I Avalos; J A Bravo; Rosa Palomera; M Bello; Roland W Sutter; Mark A Pallansch; Ciro A de Quadros
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication.
International journal of epidemiology 2001;30(5):1029-34.
2001: David R Kilpatrick; J Quay; Mark A Pallansch; Steve Oberste
Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers.
Journal of clinical microbiology 2001;39(4):1299-302.
2001: Steve Oberste; David Schnurr; Kaija Maher; Suleiman al-Busaidy; Mark A Pallansch
Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype.
The Journal of general virology 2001;82(Pt 2):409-16.
2001: Wun-Ju Shieh; S M Jung; C Hsueh; T T Kuo; AW Mounts; Umesh D Parashar; C F Yang; Jeannette Guarner; Thomas G Ksiazek; J Dawson; Cynthia Goldsmith; Gwong-Jen J Chang; S M Oberste; Mark A Pallansch; Larry J Anderson; Sherif R Zaki
Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan.
Emerging infectious diseases 2001;7(1):146-8.
2000: Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; Steve Oberste; Mark A Pallansch; Olen M Kew
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.
Journal of virology 2000;74(23):11153-61.
2000: Roland W Sutter; Ali Jaffer M Suleiman; Pradeep Malankar; Saleh M Al Khusaiby; FR Mehta; G B Clements; Mark A Pallansch; Susan E Robertson
Trial of a supplemental dose of four poliovirus vaccines.
The New England journal of medicine 2000;343(11):767-73.
2000: L G Chan; Umesh D Parashar; MS Lye; Flora Ong; S R Zaki; James P Alexander; K K Ho; Linda L Han; Mark A Pallansch; A B Suleiman; M Jegathesan; Larry J Anderson
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(3):678-83.
2000: Betty A Brown; David R Kilpatrick; Steve Oberste; Mark A Pallansch
Serotype-specific identification of enterovirus 71 by PCR.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;16(2):107-12.
2000: Steve Oberste; Kaija Maher; Mary R Flemister; G Marchetti; David R Kilpatrick; Mark A Pallansch
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses.
Journal of clinical microbiology 2000;38(3):1170-4.
1999: Steve Oberste; Kaija Maher; M L Kennett; J J Campbell; M S Carpenter; David Schnurr; Mark A Pallansch
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.
Journal of clinical microbiology 1999;37(12):3928-33.
1999: Betty A Brown; Steve Oberste; James P Alexander; M L Kennett; Mark A Pallansch
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998.
Journal of virology 1999;73(12):9969-75.
1999: Steve Oberste; Kaija Maher; Mark A Pallansch
Specific detection of echoviruses 22 and 23 in cell culture supernatants by RT-PCR.
Journal of medical virology 1999;58(2):178-81.
1999: Steve Oberste; Kaija Maher; David R Kilpatrick; Mary R Flemister; Betty A Brown; Mark A Pallansch
Typing of human enteroviruses by partial sequencing of VP1.
Journal of clinical microbiology 1999;37(5):1288-93.
1999: Steve Oberste; Kaija Maher; David R Kilpatrick; Mark A Pallansch
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.
Journal of virology 1999;73(3):1941-8.
1998: Steve Oberste; Kaija Maher; Mark A Pallansch
Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2.
Virus research 1998;58(1-2):35-43.
1998: Olen M Kew; Roland W Sutter; B K Nottay; M J McDonough; D Rebecca Prevots; L Quick; Mark A Pallansch
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.
Journal of clinical microbiology 1998;36(10):2893-9.
1998: Steve Oberste; Kaija Maher; Mark A Pallansch
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses.
Virus research 1998;56(2):217-23.
1998: David R Kilpatrick; B Nottay; Chen-Fu Yang; Su-Ju Yang; E Da Silva; Silvia Peñaranda; Mark A Pallansch; Olen M Kew
Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy.
Journal of clinical microbiology 1998;36(2):352-7.
1997: L De; Chen-Fu Yang; E Da Silva; J Boshell; P Cáceres; J R Gómez; Mark A Pallansch; Olen M Kew
Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization.
Journal of clinical microbiology 1997;35(11):2834-40.
1997: Howard E Gary; C Freeman; Silvia Peñaranda; Kaija Maher; L Anderson; Mark A Pallansch
Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine.
The Journal of infectious diseases 1997;175 Suppl 1():S264-7.
1997: Roland W Sutter; Ali Jaffer M Suleiman; Pradeep Malankar; FR Mehta; M A Medany; M A Arif; Robert W Linkins; Mark A Pallansch; M S El-Bualy; Susan E Robertson
Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
The Journal of infectious diseases 1997;175 Suppl 1():S235-40.
1997: Mary R Reichler; S Kharabsheh; Philip Rhodes; H Otoum; S Bloch; M A Majid; Mark A Pallansch; PA Patriarca; Stephen L Cochi
Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
The Journal of infectious diseases 1997;175 Suppl 1():S198-204.
1997: James P Alexander; Howard E Gary; Mark A Pallansch
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.
The Journal of infectious diseases 1997;175 Suppl 1():S176-82.
1997: Howard E Gary; R Sanders; Mark A Pallansch
A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus.
The Journal of infectious diseases 1997;175 Suppl 1():S141-5.
1997: Howard E Gary; R Sanders; Mark A Pallansch
A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: I. Factors affecting detection sensitivity in a person with acute flaccid paralysis.
The Journal of infectious diseases 1997;175 Suppl 1():S135-40.
1997: Mary R Reichler; A Abbas; S Kharabsheh; A Mahafzah; James P Alexander; Philip Rhodes; S Faouri; H Otoum; S Bloch; M A Majid; M Mulders; R Aslanian; HF Hull; Mark A Pallansch; PA Patriarca
Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan.
The Journal of infectious diseases 1997;175 Suppl 1():S62-70.
1997: P M Graves; Jill M Norris; Mark A Pallansch; I C Gerling; Marian Rewers
The role of enteroviral infections in the development of IDDM: limitations of current approaches.
Diabetes 1997;46(2):161-8.
1997: Mark A Pallansch
Coxsackievirus B epidemiology and public health concerns.
Current topics in microbiology and immunology 1997;223():13-30.
1996: David R Kilpatrick; B Nottay; Chen-Fu Yang; S J Yang; M N Mulders; Brian P Holloway; Mark A Pallansch; Olen M Kew
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.
Journal of clinical microbiology 1996;34(12):2990-6.
1996: Lone Simonsen; Ali S Khan; Howard E Gary; C Hanson; Mark A Pallansch; S Music; Robert C Holman; J A Stewart; Dean D Erdman; N H Arden; I K Arenberg; Lawrence B Schonberger
Outbreak of vertigo in Wyoming: possible role of an enterovirus infection.
Epidemiology and infection 1996;117(1):149-57.
1996: Edson E Da Silva; M T Winkler; Mark A Pallansch
Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil.
Emerging infectious diseases 1996;2(3):231-3.
1996: Robert T Chen; S Hausinger; A S Dajani; M Hanfling; Andrew L Baughman; Mark A Pallansch; PA Patriarca
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
JAMA : the journal of the American Medical Association 1996;275(21):1639-45.
1995: Betty A Brown; Mark A Pallansch
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus.
Virus research 1995;39(2-3):195-205.
1995: Rita F Helfand; Howard E Gary; C Y Freeman; Larry J Anderson; Mark A Pallansch
Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group.
The Journal of infectious diseases 1995;172(5):1206-11.
1995: Harrie van Der Avoort; B P Hull; Tapani Hovi; Mark A Pallansch; Olen M Kew; Radu Crainic; D Wood; M N Mulders; Anton M van Loon
Comparative study of five methods for intratypic differentiation of polioviruses.
Journal of clinical microbiology 1995;33(10):2562-6.
1995: E A Chervonskaya; Galina Belova; S V Maslova; T N Kutateladze; SG Drozdov; M Mulders; Mark A Pallansch; Olen M Kew; Vadim I Agol
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes.
The Journal of general virology 1995;76 ( Pt 7)():1687-99.
1995: Roland W Sutter; Mark A Pallansch; L A Sawyer; Stephen L Cochi; Stephen C Hadler
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.
Annals of the New York Academy of Sciences 1995;754():289-99.
1995: P Halonen; E Rocha; J Hierholzer; B Holloway; Timo Hyypiä; P Hurskainen; Mark A Pallansch
Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization.
Journal of clinical microbiology 1995;33(3):648-53.
1995: L De; B Nottay; Chen-Fu Yang; Brian P Holloway; Mark A Pallansch; Olen M Kew
Identification of vaccine-related polioviruses by hybridization with specific RNA probes.
Journal of clinical microbiology 1995;33(3):562-71.
1994: Peter Strebel; A Aubert-Combiescu; Niculae Ion-Nedelcu; S Biberi-Moroeanu; M Combiescu; Roland W Sutter; Olen M Kew; Mark A Pallansch; PA Patriarca; Stephen L Cochi
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
American journal of epidemiology 1994;140(12):1111-24.
1994: Rita F Helfand; Ali S Khan; Mark A Pallansch; James P Alexander; H B Meyers; R A DeSantis; Lawrence B Schonberger; Larry J Anderson
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center.
The Journal of infectious diseases 1994;169(5):1133-7.
1994: James P Alexander; L Baden; Mark A Pallansch; Larry J Anderson
Enterovirus 71 infections and neurologic disease--United States, 1977-1991.
The Journal of infectious diseases 1994;169(4):905-8.
1993: G Tambini; Jon Kim Andrus; E Marques; J Boshell; Mark A Pallansch; Ciro A de Quadros; Olen M Kew
Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater.
The Journal of infectious diseases 1993;168(6):1510-4.
1993: D P Zheng; L B Zhang; Z Y Fang; Chen-Fu Yang; M Mulders; Mark A Pallansch; Olen M Kew
Distribution of wild type 1 poliovirus genotypes in China.
The Journal of infectious diseases 1993;168(6):1361-7.
1993: Roland W Sutter; PA Patriarca; Ali Jaffer M Suleiman; Mark A Pallansch; E R Zell; P G Malankar; S Brogan; A A al-Ghassani; M S el-Bualy
Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.
International journal of epidemiology 1993;22(5):936-44.
1993: E L Durigon; Dean D Erdman; G W Gary; Mark A Pallansch; T J Torok; Larry J Anderson
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA.
Journal of virological methods 1993;44(2-3):155-65.
1993: L Mermel; D Sanchez de Mora; R W Sutter; Mark A Pallansch
Vaccine-associated paralytic poliomyelitis.
The New England journal of medicine 1993;329(11):810-1.
1993: B J Moriniere; F P van Loon; Philip H Rhodes; M L Klein-Zabban; B Frank-Senat; J E Herrington; Mark A Pallansch; PA Patriarca
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Lancet 1993;341(8860):1545-50.
1993: James P Alexander; Louisa E Chapman; Mark A Pallansch; W T Stephenson; Thomas J Török; Larry J Anderson
Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team.
The Journal of infectious diseases 1993;167(5):1201-5.
1992: C Bern; Mark A Pallansch; Howard E Gary; James P Alexander; Thomas J Török; Roger I Glass; Larry J Anderson
Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection.
American journal of epidemiology 1992;136(12):1502-6.
1992: Chen-Fu Yang; L De; S J Yang; J Ruiz Gómez; J R Cruz; Brian P Holloway; Mark A Pallansch; Olen M Kew
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala.
Virus research 1992;24(3):277-96.
1992: E G Torfason; Mark A Pallansch; C B Reimer; C Wickliffe; Harry L Keyserling
Immunoglobulin class and subclass-specific monoclonal antibody sandwich ELISA for the detection of antibodies against coxsackieviruses B, types 1-5.
Journal of virological methods 1992;37(3):289-303.
1992: Peter Strebel; Roland W Sutter; Stephen L Cochi; R J Biellik; E W Brink; Olen M Kew; Mark A Pallansch; Walter A Orenstein; Alan R Hinman
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(2):568-79.
1991: Roland W Sutter; PA Patriarca; S Brogan; P G Malankar; Mark A Pallansch; Olen M Kew; A G Bass; Stephen L Cochi; James P Alexander; D B Hall
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.
Lancet 1991;338(8769):715-20.
1991: D J Ing; Roger I Glass; P A Woods; M Simonetti; Mark A Pallansch; W D Wilcox; B L Davidson; A J Sievert
Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine.
American journal of diseases of children (1960) 1991;145(8):892-7.
1991: Chen-Fu Yang; L De; Brian P Holloway; Mark A Pallansch; Olen M Kew
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction.
Virus research 1991;20(2):159-79.
1991: Edson E Da Silva; Mark A Pallansch; Brian P Holloway; M J Oliveira; Hermann Gonçalves Schatzmayr; Olen M Kew
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil.
Intervirology 1991;32(3):149-59.
1989: L A Sawyer; Ronald C Hershow; Mark A Pallansch; D B Fishbein; P F Pinsky; S F Broerman; B B Grimm; Larry J Anderson; D B Hall; Lawrence B Schonberger
An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant.
American journal of epidemiology 1989;130(6):1187-98.
1989: M S Ho; R L Floyd; Roger I Glass; Mark A Pallansch; B Jones; B Hamby; P Woods; M E Penaranda; A Z Kapikian; G Bohan
Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
The Pediatric infectious disease journal 1989;8(10):692-6.
1987: Rebecca R Rico-Hesse; Mark A Pallansch; B K Nottay; Olen M Kew
Geographic distribution of wild poliovirus type 1 genotypes.
Virology 1987;160(2):311-22.
1987: B B Hamby; Mark A Pallansch; Olen M Kew
Reemergence of an epidemic coxsackievirus B5 genotype.
The Journal of infectious diseases 1987;156(2):288-92.
1984: Mark A Pallansch; Olen M Kew; B L Semler; D R Omilianowski; C W Anderson; E Wimmer; R R Rueckert
Protein processing map of poliovirus.
Journal of virology 1984;49(3):873-80.
1981: R R Rueckert; Mark A Pallansch
Preparation and characterization of encephalomyocarditis (EMC) virus.
Methods in enzymology 1981;78(Pt A):315-25.
1980: Mark A Pallansch; Olen M Kew; A C Palmenberg; F Golini; E Wimmer; R R Rueckert
Picornaviral VPg sequences are contained in the replicase precursor.
Journal of virology 1980;35(2):414-9.
1980: Olen M Kew; Mark A Pallansch; D R Omilianowski; R R Rueckert
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.
Journal of virology 1980;33(1):256-63.